Graduate coursework (24 hours), Master of Health Sciences
Duke University School of Medicine, Durham, NC
University of North Carolina at Charlotte, Charlotte, NC
Deirdre Mladsi is Head of Health Economics-Strategy and Early Modeling at RTI-HS, applying methods and experience to support development and commercialization of pharmaceuticals, medical devices, and diagnostics. She has over 25 years of experience conducting health economics and outcomes research, including 5 years in the Global Health Outcomes group of a leading research-based pharmaceutical company. As a consultant, Ms. Mladsi, one of the founding senior members of RTI-HS, has established and led several teams within the organization; she served as one of the first two Directors of Health Economics, as the first Global Head of Health Outcomes Strategy (now Market Access and Outcomes Strategy), and as the first Global Head of Pricing and Reimbursement, before returning to Health Economics to organize the Strategy and Early Modeling offering.
As Head of Health Economics-Strategy and Early Modeling, Ms. Mladsi blends her technical skills in health economics with her experience conducting strategic pricing, reimbursement, and market access projects. Areas of specialization that blend health economics and market access include threshold analysis to estimate value-based price opportunity, given an expected product profile; valuation modeling to inform clinical development prioritization efforts; and decision support modeling targeted at payers and other health care market access decision makers.
Ms. Mladsi leads teams with a focus on generating high quality research in an efficient, timely manner emphasizing appreciation of the strategic importance of the project, consideration of the real world context into which the research will fit, and importance of clear and proactive communication among all project team members. Ms. Mladsi also routinely leads cross-disciplinary portfolio projects, bringing multidisciplinary experience and strategic direction to ensure that individual projects (e.g., models, literature reviews, trial analyses, indirect treatment comparisons, payer research) contribute complementary evidence to support an overarching value story. In addition to health economics, her interest is in bringing together scientists and marketing professionals to ensure that clear, concise, and relevant information is placed in the hands of marketplace decision makers, facilitating patient access to valuable new health care technologies.
Ms. Mladsi’s training is in economics and applied biostatistics, with an emphasis on clinical research. Although she has worked in all primary therapeutic areas, for several years her primary focus was oncology. She has published (also under the name Neighbors) in the Journal of Clinical Oncology, Journal of Pain and Symptom Management, Journal of Health Economics, Pharmacoeconomics, and Value in Health, and has presented at numerous professional conferences. She has served as an adjunct faculty of Campbell University, responsible for their Health Economics course, offered as part of their Master's in Clinical Research program.